Zidebactam

Generic Name: Zidebactam

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₃H_₂₁N_₅O_₇S

CAS Number: 1436861-97-0

Unique Ingredient Identifier: YPM97423DB

Background: Zidebactam is under investigation in clinical trial NCT02674347 (MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)

Phase 1

Completed

Conditions: Bacterial Infection

Interventions: Drug: Ertapenem
Other: Placebo
Drug: WCK 6777
Drug: Zidebactam

First Posted Date: 2022-12-09

Last Posted Date: 2024-12-05

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 54

Registration Number: NCT05645757

Locations: 🇺🇸
Altasciences Inc - Kansas City, Overland Park, Kansas, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy